NBTX

Nanobiotix S.A.

• TipRanks·1d ago

  Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright

• TipRanks·6d ago

  Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026

• Reuters·6d ago

  Nanobiotix reports 48,517,630 issued shares, 50,143,014 exercisable voting rights

• Benzinga·04/02 14:09

  Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

• TipRanks·04/02 10:55

  Nanobiotix price target raised to $36 from $26 at Guggenheim

• TipRanks·04/01 20:35

  Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile

• TipRanks·04/01 15:20

  Nanobiotix price target raised to $37 from $26 at Leerink

• NASDAQ·04/01 07:46

  Nanobiotix FY25 Net Loss Narrows; Expects Cash Runway Through Early 2028; Stock Down

• TipRanks·04/01 02:42

  Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed

• Reuters·03/31 23:19

  Nanobiotix publishes 2025 annual report

• Benzinga·03/31 20:26

  Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

• Seeking Alpha·03/31 20:20

  Nanobiotix GAAP EPS of -€0.50, revenue of €29.6M

• Reuters·03/31 20:15

  BRIEF-Nanobiotix S.A. FY Revenue EUR 32.6 Million

• Benzinga·03/31 11:11

  Earnings Scheduled For March 31, 2026